Form 4 for CAH Cardinal Health
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0000721371-23-000114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | 2023-12-01 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | F - Tax | $107.08 | -638 | 34.6K | -2% | -$68.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-12-01 | F | D | 638 | $107.08 | 34,564 | D | — | — | (F2) Reflects closing price on prior business day. |